Go Pro
Morten Herholdt

Morten Herholdt Analyst Performance

Equity Research Analyst at HSBC

Morten Herholdt is a stock analyst at HSBC in the healthcare sector, covering 4 publicly traded companies. Over the past year, Morten Herholdt has issued 6 stock ratings, including buy, hold, and sell recommendations. While full access to Morten Herholdt's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Morten Herholdt's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
6 Last 0 Years
Buy Recommendations
66.67% 4 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%4 ratings
Hold16.7%1 ratings
Sell16.7%1 ratings

Out of 6 total stock ratings issued by Morten Herholdt at HSBC, the majority (66.7%) have been Buy recommendations, followed by 16.7% Hold and 16.7% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
3 companies
NYSE
25.0% of companies on NYSE
1 company

Morten Herholdt, an analyst at HSBC, currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
4 companies
100.0%

Morten Herholdt of HSBC specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
3 companies
75.0%
PHARMACEUTICALS
1 company
25.0%

Morten Herholdt's Ratings History at HSBC

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
9/10/2026Boost Price Target$267.20$320.00Buy
Biogen Inc. stock logo
BIIB
Biogen
9/10/2026Boost Price Target$210.73$175.00Reduce
Amgen Inc. stock logo
AMGN
Amgen
9/10/2026Downgrade$391.27$425.00Hold
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
9/10/2026Boost Price Target$145.10$175.00Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/6/2026Set Price Target$259.19$290.00Buy
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
3/17/2026Boost Price Target$240.79$280.00Buy